Management of venous thromboembolic diseases

• National Institute for Health and Care Excellence •

1. People with suspected deep vein thrombosis are offered an interim therapeutic dose of anticoagulation therapy if diagnostic investigations are expected to take longer than 4 hours from the time of first clinical suspicion.
2. People with suspected deep vein thrombosis have all diagnostic investigations completed within 24 hours of first clinical suspicion.
3. People with suspected pulmonary embolism are offered an interim therapeutic dose of anticoagulation therapy if diagnostic investigations are expected to take longer than 1 hour from the time of first clinical suspicion.
4. People with proximal deep vein thrombosis are offered below-knee graduated compression stockings within 3 weeks of diagnosis.
5. People with unprovoked deep vein thrombosis or pulmonary embolism who are not already known to have cancer are offered timely investigations for cancer.
6. People with provoked deep vein thrombosis or pulmonary embolism are not offered testing for thrombophilia.
7. People with active cancer and confirmed proximal deep vein thrombosis or pulmonary embolism are offered anticoagulation therapy.
8. People without cancer who receive anticoagulation therapy have a review within 3 months of diagnosis of confirmed proximal deep vein thrombosis or pulmonary embolism to discuss the risks and benefits of continuing anticoagulation therapy.
9. People with active cancer who receive anticoagulation therapy have a review within 6�? months of confirmed proximal deep vein thrombosis or pulmonary embolism to discuss the risks and benefits of continuing anticoagulation therapy.

full quality standards including quality measures avaliable from…
National Institute for Health and Care Excellence, MidCity Place
Tel – http://www.nice.org.uk/guidance/qualitystandards/qualitystandards.jsp

National Institute for Health and Care Excellence. Quality Standards Programme: Management of venous thromboembolic diseases. March 2013